{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-256D",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-256D.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "regulation/256D",
  "kind": "regulation",
  "number": "256D",
  "heading": "Procedure for listing persons who may supply medicinal products at a distance",
  "text": "(1) If the licensing authority receives a notification under regulation 256C it must accept or refuse to include that person on the list within the period of 90 days beginning immediately after the day on which the notification is received by the authority.\n(2) Paragraph (1) applies only if the requirements of regulation 256C(2) have been met.\n(3) Before determining if a person can be included on the list, the licensing authority may require the person giving the notification to provide such information as the licensing authority thinks necessary, within the period specified by the licensing authority.\n(4) If a notice under paragraph (3) requires the person giving the notification to provide the licensing authority with information, the information period is not to be counted for the purposes of paragraph (1).\n(5) In paragraph (4), the “information period” means the period—\n(a) beginning with the day on which the notice is given, and\n(b) ending with the day on which—\n(i) the licensing authority receives the information; or\n(ii) the person from whom the information is requested shows to the satisfaction of the licensing authority that the information cannot be provided.\n(6) The licensing authority must give the person giving the notification a notice stating reasons for its decision in any case where—\n(a) the licensing authority refuses to include the person giving the notification on the list; or\n(b) if the licensing authority lists the person giving the notification otherwise that in accordance with the information supplied in the notification.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Pt. 12A inserted (coming into force in accordance with reg. 1(2) of the amending S.I.) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(2), 28"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in regs. 256C-256M substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 197(4) (as substituted by S.I. 2020/1488, reg. 1, Sch. 2 para. 151); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in reg. 256D(3) substituted (31.12.2020) by S.I. 2019/775, regs. 1, 197(6) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 151)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/regulation/256D",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}